A detailed history of Primecap Management CO transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Primecap Management CO holds 273,730 shares of CRL stock, worth $54.4 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
273,730
Previous 273,930 0.07%
Holding current value
$54.4 Million
Previous $74.2 Million 23.81%
% of portfolio
0.04%
Previous 0.06%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$206.39 - $268.73 $41,278 - $53,746
-200 Reduced 0.07%
273,730 $56.5 Million
Q3 2023

Nov 13, 2023

SELL
$194.44 - $217.61 $9,722 - $10,880
-50 Reduced 0.02%
273,930 $53.7 Million
Q1 2023

May 15, 2023

SELL
$191.89 - $259.92 $2.06 Million - $2.8 Million
-10,760 Reduced 3.78%
273,980 $55.3 Million
Q4 2022

Feb 13, 2023

SELL
$197.11 - $250.07 $1.99 Million - $2.52 Million
-10,080 Reduced 3.42%
284,740 $62 Million
Q3 2022

Nov 14, 2022

SELL
$182.44 - $250.54 $189,737 - $260,561
-1,040 Reduced 0.35%
294,820 $58 Million
Q2 2022

Aug 11, 2022

SELL
$204.13 - $302.4 $5.93 Million - $8.78 Million
-29,030 Reduced 8.94%
295,860 $63.3 Million
Q1 2022

May 11, 2022

SELL
$255.51 - $362.11 $8.4 Million - $11.9 Million
-32,890 Reduced 9.19%
324,890 $92.3 Million
Q4 2021

Feb 11, 2022

SELL
$351.38 - $448.68 $2.47 Million - $3.16 Million
-7,040 Reduced 1.93%
357,780 $135 Million
Q3 2021

Nov 12, 2021

SELL
$372.64 - $458.3 $257,121 - $316,227
-690 Reduced 0.19%
364,820 $151 Million
Q2 2021

Aug 10, 2021

SELL
$294.17 - $371.65 $1.4 Million - $1.77 Million
-4,750 Reduced 1.28%
365,510 $135 Million
Q1 2021

May 14, 2021

SELL
$249.67 - $299.48 $42,443 - $50,911
-170 Reduced 0.05%
370,260 $107 Million
Q4 2020

Feb 08, 2021

SELL
$222.0 - $252.62 $237,540 - $270,303
-1,070 Reduced 0.29%
370,430 $92.6 Million
Q3 2020

Nov 13, 2020

SELL
$175.56 - $226.45 $895,356 - $1.15 Million
-5,100 Reduced 1.35%
371,500 $84.1 Million
Q2 2020

Aug 13, 2020

SELL
$118.84 - $189.72 $178,260 - $284,580
-1,500 Reduced 0.4%
376,600 $65.7 Million
Q1 2020

May 14, 2020

SELL
$98.9 - $178.34 $405,490 - $731,194
-4,100 Reduced 1.07%
378,100 $47.7 Million
Q4 2019

Feb 14, 2020

SELL
$126.05 - $152.76 $176,470 - $213,864
-1,400 Reduced 0.36%
382,200 $58.4 Million
Q3 2019

Nov 13, 2019

SELL
$125.07 - $143.67 $1.43 Million - $1.64 Million
-11,400 Reduced 2.89%
383,600 $50.8 Million
Q2 2019

Aug 14, 2019

SELL
$123.4 - $148.55 $1.11 Million - $1.34 Million
-9,000 Reduced 2.23%
395,000 $56.1 Million
Q1 2019

May 14, 2019

SELL
$104.82 - $146.73 $10,482 - $14,672
-100 Reduced 0.02%
404,000 $58.7 Million
Q4 2018

Feb 12, 2019

SELL
$105.09 - $137.23 $1.79 Million - $2.33 Million
-17,000 Reduced 4.04%
404,100 $45.7 Million
Q3 2018

Nov 13, 2018

SELL
$112.11 - $134.54 $336,330 - $403,620
-3,000 Reduced 0.71%
421,100 $56.7 Million
Q2 2018

Aug 13, 2018

SELL
$102.37 - $117.25 $20,474 - $23,450
-200 Reduced 0.05%
424,100 $47.6 Million
Q1 2018

May 14, 2018

SELL
$98.19 - $115.2 $157,104 - $184,320
-1,600 Reduced 0.38%
424,300 $45.3 Million
Q4 2017

Feb 13, 2018

SELL
$100.43 - $118.09 $30,129 - $35,427
-300 Reduced 0.07%
425,900 $46.6 Million
Q3 2017

Nov 13, 2017

BUY
$96.72 - $109.26 $41.2 Million - $46.6 Million
426,200
426,200 $46 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Primecap Management CO Portfolio

Follow Primecap Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Primecap Management CO with notifications on news.